Patrick Bertrand

Patrick Bertrand has 20 years of experience in advocating for global health. He is the Director and founder of Global Health Advocates France, a leading NGO focused on generating political momentum for Global Health on a domestic and international scale. He is a founding member of the Action for Global Health Network, a European coalition consisting of 15 European NGOs based in 5 countries focused on health MDGs. and the ACTION Global Health Advocacy Partnership an international coalition across the UK, US, France, Japan, Australia, Japan, India, Kenya and Zambia advocating for more resources dedicated to TB control and child health. GHA also coordinated the TB Europe Coalition in Brussels, which represent the NGO community in to development of the WHO Europe MDR-TB Action Plan. As Principal Partner of Global Health Advocates Switzerland, Patrick Bertrand led the ACTION Partnership strategy and program implementation within Kenya and developed successful TB proposals for the Global Fund to Fight AIDS, TB, and Malaria in the Democratic Republic of Congo and Nigeria. Patrick Bertrand has a master in Communications from the University of Grenoble, France.

 Global Health Advocates France (GHA) mobilizes society against diseases that keep people in poverty. Our advocacy is focusing on ensuring that European and French policies deliver a comprehensive and pro-active response to confront the need for innovation and access to medicines, vaccines and quality health care for the poorest people worldwide.

GHA is a founding member of the ACTION Partnership and the Action for Global Health network. As part of this effort, we act as a convenor and coordinate a number of coalitions including the European Parliament working group on innovation, access to medicines and poverty-related diseases, jointly with Médecins sans Frontières, the Europe TB coalition and the European immunisation and vaccines advocacy coalition.

More specifically, GHA advocates on immunisation towards:
  • Increasing resources for immunisation from French and EU institutions
  • Ensuring that the EU and FR institutions adequately address the issue of access to immunisation for developing countries with equity focused policies
  • Strengthening civil society capacity on vaccine advocacy both at the European Union and international level